P512: A PHASE 1B/2 STUDY OF TP‐0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS

Bibliographische Detailangaben

Veröffentlicht in:	HemaSphere 2023-08, Vol.7 (S3), p.e2938119-n/a
Hauptverfasser:	Mims, Alice, Huang, Ying, Eisenmann, Eric, Orwick, Shelley, Buelow, Daelynn, Swords, Ronan, Zeidner, Joshua, Foster, Matthew, L. Lin, Tara, Baer, Maria, Madanat, Yazan, Kovacsovics, Tibor, Redner, Robert, Al‐Mansour, Zeina, Stefanos, Mona, Martycz, Molly, Druggan, Franchesca, Chen, Timothy, Yocum, Ashley, Borate, Uma, Druker, Brian, Burd, Amy, Levine, Ross, Baker, Sharyn, C. Byrd, John
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!